NCT06864416View on ClinicalTrials.gov

Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

November 1, 2024

Conditions
Post Operative Pain
Interventions
DRUG

dexmedetomidine as adjuvant to bupivacaine

the efficacy of addition of dexmedetomidine as adjuvants to bupivacaine in femorosciatic nerve block

DRUG

Fentanyl as adjuvant to bupivacaine

the efficacy of addition of fentanyl as adjuvants to bupivacaine in femorosciatic nerve block

Trial Locations (1)

Unknown

Ain Shams University, abbasia, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06864416 - Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine | Biotech Hunter | Biotech Hunter